Updated drug information handout outdoes FDA’s version in clinical trial

A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an updated version developed by researchers at the University of Pittsburgh that quantifies a drug’s risk and benefits showed that the latter was more informative and helped patients feel better equipped to make decisions.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup